Federal Register / Vol. 80, No. 66 / Tuesday, April 7, 2015 / Notices 18639 

panels included in figures in Cell 2011, 

Nature 2013, and the unpublished 

manuscript. Respondent inflated sample 

numbers and data, fabricated numbers 

for data sets, manipulated enzymelinked immunosorbent assay (ELISA) 

analysis, mislabelled 

immunoflourescent confocal images, 

and manipulated and reused Western 

blot images. 

Specifically, the Respondent 

• Fabricated numbers for the data 

presented as a bar graph in nine (9) 

panels in Figures S6#, S6H, and S6J 

in Cell 2011, Figures 3B and S12 in 

Nature 2013, and Figures 2F, 4B, 4D, 

and 4F in the unpublished 

manuscript 

Falsely inflated the sample size of 

quantitative data presented as bar 

graphs in fifty-three (53) panels in 

Figures 6B, 7I, and S6J in Cell 2011, 

Figures 3G, 3H, 4C, S10, S11b–h, 

S12d–f, S13a, S13c, S14b–c, S15b–i, 

and S16a–f in Nature 2013, and 

Figures 4b, 4d, 4f, 4i, 6c–d, S1n, S1o, 

S2a–b, and S4c–k in the unpublished 

manuscript 

Falsely manipulated ELISA analysis to 

achieve desired results presented as 

bar graphs in nine (9) figure-panels in 

Figure 6B in Cell 2011 and Figures 

2D, 2E, 3G, 3H, and S10a–d in Nature 

2013 

Falsely inflated the numerical values of 

the data in Figure 7I in Cell 2011 by 

a factor of 10 to improve results and 

appear consistent with data presented 

in supplementary information 

published with the paper 

Falsely reversed the labeling of 

immunoflourescent confocal images 

in Figures 7M and 7N in Cell 2011 

and Figure S13A in Nature 2013 to 

obtain the desired results 

Flipped and resized the Western blot 

image for APP panel from Figure 12b 

and falsely reused it to represent APP 

results under completely different 

experimental conditions in Figure 12c 

in Nature 2013 

Dr. Fujita has entered into a Voluntary 

Exclusion Agreement (Agreement) and 

has voluntarily agreed for a period of 

three (3) years, beginning on March 18, 

2015: 

(1) to exclude himself from any 

contracting or subcontracting with any 

agency of the United States Government 

and from eligibility for or involvement 

in nonprocurement programs of the 

United States Government referred to as 

‘‘covered transactions’’ pursuant to 

HHS’ Implementation (2 CFR part 376 et 

seq) of OMB Guidelines to Agencies on 

Governmentwide Debarment and 

Suspension, 2 CFR part 180 (collectively 

the ‘‘Debarment Regulations’’); and 

(2) to exclude himself voluntarily 

from serving in any advisory capacity to 

the U.S. Public Health Service (PHS) 

including, but not limited to, service on 

any PHS advisory committee, board, 

and/or peer review committee, or as a 

consultant. 

FOR FURTHER INFORMATION CONTACT: 

Acting Director, Office of Research 

Integrity, 1101 Wootton Parkway, Suite 

750, Rockville, MD 20852, (240) 453– 

8200. 

Donald Wright, 

Acting Director, Office of Research Integrity. 

[FR Doc. 2015–07897 Filed 4–6–15; 8:45 am] 

BILLING CODE CODE 4150–31–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Meeting of the National Advisory 

Committee on Children and Disasters 

AGENCY: Office of the Secretary, 

Department of Health and Human 

Services. 

ACTION: Notice. 

SUMMARY: As stipulated by the Federal 

Advisory Committee Act, the 

Department of Health and Human 

Services (HHS) is hereby giving notice 

that the National Advisory Committee 

on Children and Disasters (NACCD) will 

be holding a meeting via teleconference. 

The meeting is open to the public. 

DATES: The April 30, 2015, NACCD 

meeting is scheduled from 1:00 p.m. to 

2:00 p.m. EST. The agenda is subject to 

change as priorities dictate. Please 

check the NACCD Web site, located at 

WWW.PHE.GOV/NACCD for the most 

up-to-date information on the meeting. 

ADDRESSES: To attend the meeting via 

teleconference, call toll-free: 1–888– 

324–4311, international dial-in: 1–517– 

308–9181. The pass-code is: 4818002. 

Please call 15 minutes prior to the 

beginning of the conference call to 

facilitate attendance. Pre-registration is 

required for public attendance. 

Individuals who wish to attend the 

meeting should submit an inquiry via 

the NACCD Contact Form located at 

www.phe.gov/NACCDComments. 

FOR FURTHER INFORMATION CONTACT: 

Please submit an inquiry via the NACCD 

Contact Form located at www.phe.gov/

NACCDComments. 

SUPPLEMENTARY INFORMATION: Pursuant 

to the Federal Advisory Committee Act 

(FACA) of 1972 (5 U.S.C., Appendix, as 

amended), and section 2811A of the 

Public Health Service (PHS) Act (42 

U.S.C. 300hh–10a), as added by section 

103 of the Pandemic and All Hazards 

Preparedness Reauthorization Act of 

2013 (Pub. L. 113–5), the HHS 

Secretary, in consultation with the 

Secretary of the U.S. Department of 

Homeland Security, established the 

National Advisory Committee on 

Children and Disasters (NACCD). The 

purpose of the NACCD is to provide 

advice and consultation to the HHS 

Secretary with respect to the medical 

and public health needs of children in 

relation to disasters. The Office of the 

Assistant Secretary for Preparedness 

and Response (ASPR) provides 

management and administrative 

oversight to support the activities of the 

NACCD. 

Background: This public meeting will 

be dedicated to the members voting to 

approve the report of findings of the 

NACCD Surge Capacity Work Group. 

Availability of Materials: The meeting 

agenda and materials will be posted on 

the NACCD Web site at: www.phe.gov/ 

naccd prior to the meeting. 

Procedures for Providing Public Input: 

All written comments must be received 

prior to April 29, 2015. Please submit 

comments via the NACCD Contact Form 

located at www.phe.gov/

NACCDComments. Individuals who 

plan to participate by phone and need 

special assistance should submit a 

request via the NACCD Contact Form 

located at www.phe.gov/

NACCDComments. 

Dated: March 18, 2015. 

Nicole Lurie, 

Assistant Secretary for Preparedness and 

Response. 

[FR Doc. 2015–07874 Filed 4–6–15; 8:45 am] 

BILLING CODE CODE P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Indian Health Service 

Reimbursement Rates for Calendar 

Year 2015 

AGENCY: Indian Health Service, HHS. 

ACTION: Notice. 

SUMMARY: Notice is given that the 

Director of the Indian Health Service 

(IHS), under the authority of sections 

321(a) and 322(b) of the Public Health 

Service Act (42 U.S.C. 248 and 249(b)), 

Public Law 83–568 (42 U.S.C. 2001(a)), 

and the Indian Health Care 

Improvement Act (25 U.S.C. 1601 et 

seq.), has approved the following rates 

for inpatient and outpatient medical 

care provided by IHS facilities for 

Calendar Year 2015 for Medicare and 

Medicaid beneficiaries, and 

beneficiaries of other Federal programs, 

mstockstill on DSK4VPTVN1PROD with NOTICES

18640 Federal Register / Vol. 80, No. 66 / Tuesday, April 7, 2015 / Notices 

and for recoveries under the Federal 

Medical Care Recovery Act (42 U.S.C. 

§§ 2651–2653). The Medicare Part A 

inpatient rates are excluded from the 

table below as they are paid based on 

the prospective payment system. Since 

the inpatient rates set forth below do not 

include all physician services and 

practitioner services, additional 

payment shall be available to the extent 

that those services are provided. 

Calendar 

Year 

2015 

Inpatient Hospital Per Diem Rate 

(Excludes Physician/Practitioner 

Services) 

Lower 48 States ........................... $2,443 

Alaska ........................................... 2,926 

Outpatient Per Visit Rate (Excluding Medicare) 

Lower 48 States ........................... 350 

Alaska ........................................... 601 

Outpatient Per Visit Rate (Medicare) 

Lower 48 States ........................... 307 

Alaska ........................................... 564 

Medicare Part B Inpatient Ancillary Per Diem Rate 

Lower 48 States ........................... 516 

Alaska ........................................... 956 

Outpatient Surgery Rate (Medicare) 

Established Medicare rates for 

freestanding Ambulatory Surgery 

Centers. 

Effective Date for Calendar Year 2015 

Rates 

Consistent with previous annual rate 

revisions, the Calendar Year 2015 rates 

will be effective for services provided 

on/or after January 1, 2015 to the extent 

consistent with payment authorities 

including the applicable Medicaid State 

plan. 

Dated: December 12, 2014. 

Yvette Roubideaux, 

Acting Director, Indian Health Service. 

Editorial Note: The Federal Register 

received this document for publication on 

March 31, 2015. 

[FR Doc. 2015–07779 Filed 4–6–15; 8:45 am] 

BILLING CODE 4160–16–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Submission for OMB Review; 30-day 

Comment Request; National Institute 

of Health Neurobiobank Tissue Access 

Request 

SUMMARY: Under the provisions of 

Section 3507(a)(1)(D) of the Paperwork 

Reduction Act of 1995, the National 

Institutes of Health (NIH) has submitted 

to the Office of Management and Budget 

(OMB) a request for review and 

approval of the information collection 

listed below. This proposed information 

collection was previously published in 

the Federal Register on February 13, 

2014, page 8723 and allowed 60-days 

for public comment. No public 

comments were received. The purpose 

of this notice is to allow an additional 

30 days for public comment. The 

National Institute of Mental Health 

(NIMH), National Institutes of Health, 

may not conduct or sponsor, and the 

respondent is not required to respond 

to, an information collection that has 

been extended, revised, or implemented 

on or after October 1, 1995, unless it 

displays a currently valid OMB control 

number. 

Direct Comments to OMB: Written 

comments and/or suggestions regarding 

the item(s) contained in this notice, 

especially regarding the estimated 

public burden and associated response 

time, should be directed to the: Office 

of Management and Budget, Office of 

Regulatory Affairs, OIRA_submission@

omb.eop.gov or by fax to 202–395–6974, 

Attention: NIH Desk Officer. 

Comment Due Date: Comments 

regarding this information collection are 

best assured of having their full effect if 

received within 30-days of the date of 

this publication. 

FOR FURTHER INFORMATION CONTACT: To 

obtain a copy of the data collection 

plans and instruments or request more 

information on the proposed project 

contact: NIMH Project Clearance 

Liaison, Science Policy and Evaluation 

Branch, OSPPC, NIMH, NIH, 

Neuroscience Center, 6001 Executive 

Boulevard, MSC 9667, Rockville Pike, 

Bethesda, MD 20892, or call 301–443– 

4335 or Email your request, including 

your address to: 

nimhprapubliccomments@mail.nih.gov. 

Formal requests for additional plans and 

instruments must be requested in 

writing. 

Proposed Collection: National 

Institute of Health Neurobiobank Tissue 

Access Request—Existing without OMB 

Clearance—National Institute of Mental 

Health (NIMH), National Institute of 

Health (NIH). 

Need and Use of Information 

Collection: NIMH is seeking OMB 

approval for two Neurobiobank data 

collections: (1) Pre-Mortem Donor 

Recruitment Form, and (2) Tissue 

Access Request Form. The pre-mortem 

donor form will collect information 

from potential donors to ensure and 

enable appropriate research use of the 

tissues and biospecimens. Knowledge 

about the health history surrounding a 

particular tissue or biospecimen is 

essential to ethical scientific research 

conducted upon it. The tissue access 

request form will collect information 

from researchers who wish to gain 

access to the tissue stored throughout 

the Neurobiobank network, The NIH 

Neurobiobank Tissue Access Request 

form is necessary to verify that the 

researcher ‘‘Recipient’’ Principal 

Investigators and their organization or 

corporations applying to use the tissue 

is qualified to conduct human tissue 

research and have approved assurance 

from the DHHS Office of Human 

Research Protections to access tissue or 

biospecimens from the National 

Neurobiobank for research purposes. 

The primary use of this information is 

to document, track, monitor, and 

evaluate the appropriate use of the 

Neurobiobank tissue and biospecimen 

resources, as well as to notify interested 

recipients of updates, corrections, or 

other changes to the system. 

OMB approval is requested for 3 

years. There are no costs to respondents 

other than their time. The total 

estimated annualized burden hours are 

38. 

ESTIMATED ANNUALIZED BURDEN HOURS

Form Number of 

respondents 

Frequency of 

response 

Average 

burden per 

response 

(in hours) 

Total annual 

burden hours 

Neurobiobank Tissue Access Request ............................................................ 50 1 30/60 25 

Pre-Mortem Donor Recruitment Form ............................................................. 50 1 15/60 13 

Total .......................................................................................................... 100 ........................ ........................ 38 

mstockstill on DSK4VPTVN1PROD with NOTICES